This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kura Oncology, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ana Rita Neves: Innovator in Pharmaceutical Compounds
Introduction
Ana Rita Neves is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of macrocyclic compounds. Her work is crucial in advancing treatments for various medical conditions, including cancer.
Latest Patents
Ana Rita Neves holds a patent titled "Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same." This patent relates to solid forms of Compound 1, or a pharmaceutically acceptable form thereof, including its salts and solvates. The pharmaceutical compositions she developed are aimed at treating cancer that depends on a farnesylated protein, showcasing her innovative approach to drug formulation.
Career Highlights
Ana Rita Neves is currently employed at Kura Oncology, Inc., where she continues to push the boundaries of pharmaceutical research. Her expertise in macrocyclic compounds has positioned her as a key player in the development of new therapeutic strategies.
Collaborations
Ana Rita collaborates with Kenneth K Liu, leveraging their combined expertise to enhance the research and development of innovative pharmaceutical solutions.
Conclusion
Ana Rita Neves exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Kura Oncology, Inc. are paving the way for new treatments that could significantly impact cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile